Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.iOnctura receives orphan drug status for pancreatic cancer therapy
Cambritaxestat is currently being tested along with chemotherapy in the Phase I AION-02 study for metastatic pancreatic cancer. Credit: Michal Jarmoluk from Pixabay.
Cambritaxestat is currently being tested along with chemotherapy in the Phase I AION-02 study for metastatic pancreatic cancer. Credit: Michal Jarmoluk from Pixabay.